Abstract
Background and Objective: As a part of a medication error prevention policy, various ordinances in the field of medicine had been promulgated, and each pharmaceutical corporation has become obligatory to take measures regarding their own products. One of the authors, who worked during the time as a leader in this field in a pharmaceutical corporation, aimed to create countermeasures to meet these ordinances.
Method and Result: The range of the problem is so broad from naming, formulation, container/package, indication, to information activity, that just one department could not cover every issue. So, this author started a project, which later led to an official meeting, comprising members from related departments in order to discuss how to meet the series of ordinances, besides voices from medical fields.
]Through the process of the corporation work, all the people became more interested in this field, and succeeded in creating various effective countermeasures, as well as in starting a new study meeting outside the company to deal with the suggestions from medical institutes.
Discussion: "Safety in use'' has become more and more important and critical, being equal to the quality (quality of pharmaceutical product) problem and the safety (adverse effect) problem in medical safety, and thus it has to be handled as a nationwide matter, besides the pharmaceutical industry, involving all the related parties such as medical staff, patients and sometimes legal people.
